Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

Video Abstract: Simplified Ankylosing Spondylitis Disease Activity Score ( SASDAS) Versus ASDAS

PDF) Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome

Ankylosing Spondylitis: Most Up-to-Date Encyclopedia, News & Reviews

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

Panlar recommendations for the management of ax Sp A - nature reviews rheumatology - Studocu

PDF) The Journal of Rheumatology Spondyloarthritis During Treatment with Adalimumab Performance of 3 Enthesitis Indices in Patients with Peripheral

Disease Control Data, Ankylosing Spondylitis

Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts

Scatter plots showing correlation of SASDAS with ASDAS

PDF) Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Bland-Altman plots for (A) baseline pooled treatment; (B) week 12 PBO;

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial

Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis - ScienceDirect